Alliance for Clinical Trials in Oncology A032201/STRIKE - a trial for patients with renal cell cancer, led by Bradley McGregor Dana-Farber Dan George Duke Cancer, is currently enrolling trial participants at more than 200 sites across the country, including Metro-MN Community Oncology Research Consortium!

Patients with prostate cancer and their caretakers--join the Boston Prostate Cancer Support Group tonight, 6-8 pm EDT. bostonprostatecancer.org 6-7: Patient-led subgroups 7-8: Atish Choudhury, MD PhD from Dana-Farber Lank Center for Genitourinary Oncology speaks on emerging therapeutics!

Giuseppe Carnevali Endowed Lecture “Unravelling the Mysteries of Kidney Cancer – A Journey from Genetics to Immunology” Dr. Samra Turajlic, MD The Francis Crick Institute The Royal Marsden Cancer Charity A masterclass in Kidney Cancer genetics, evolution and immunity. And congrats on her new adventure

Welcoming Prateek Khanna as new faculty to the Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber —Prateek had excellent lab and clinical training in GU cancers (Srinivas Viswanathan, Rupal Bhatt BIDMC)! He just came back from #VailWorkshop ASCO AACR and he is ready to take over the world!

GU Research Digest for the week of August 2 - 8: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

We congratulate Srinivas Viswanathan, MD, PhD, a 2025 AACR-@KidneyCAN Kidney Cancer Innovation and Discovery Grant recipient. We look forward to his work on TFE3 fusion inhibitors for translocation renal cell carcinoma, a rare kidney cancer with no approved targeted therapies.

GU Research Digest for the week of August 9 - 15: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

Honored to give 2 talks last week at the Gordon: Hormone-Dependent Cancers! Huge thanks to organizers for the invitation. Special thanks to my mentor, Misha Beltran, for her incredible support. Loved learning, sharing ideas, and feeling the warmth of this amazing #GRC community.

New research out from lead author Balaji and senior author Misha Beltran on the role of transcription factor PROX1 in transformation into neuroendocrine prostate cancer. Out now in Cancer Research Cancer Research #BeltranLab aacrjournals.org/cancerres/arti…

Some prostate cancers evade therapy by transforming into aggressive neuroendocrine prostate cancer. New research highlights PROX1 as a key driver of this transformation and tumor growth, offering a potential treatment target. ➡️ bit.ly/4lEFHoD Cancer Research @bajji

Last session the ‘Good News’ with Charles Ryan & Alicia Morgans, MD, MPH GoodNews AboutCancer ‘We have hope and a bright future’ 🥰 #WorldGU25

GU Research Digest for the week of August 16 - 22: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

Another extraordinary day! Thrilled.. the legendary Sir Roger Daltrey Roger Daltrey came to visit our Young Adult Lounge and listen to patients. Teen Cancer America The Who 🙏🏼 for your work & advocacy! ‘A world free of the fear and burden of cancer’ Dana-Farber

#CheckMate214 final overall survival data: Long-term survival benefits of ipi/nivo in #KidneyCancer. Michael Serzan, MD Dana-Farber joins Pedro C Barata, MD MSc FACP Case Comp Cancer Ctr to discuss data demonstrating maintained OS benefit in intermediate- and poor-risk patients with over eight years follow-up,

Thank you for the invitation to present, PathfinderDFHCC! Excited to discuss our recent work published in Cancer Research at this 'micro' journal club where I'll summarize the paper in < 10 min, followed by a discussion. Open to all. Register if interested! Misha Beltran Dana-Farber Lank Center for Genitourinary Oncology

GU Research Digest for the week of August 23 - 29: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

GU Research Digest for the week of August 30 - September 5: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

Thank you prostate scientist-extraordinaire Josh Lang for coming to our Dana-Farber Grand Rounds “Sweeney Lecture @si. Elegant work in CTC at the crossroads of translational research and bioengineering! cc: Dana-Farber Lank Center for Genitourinary Oncology Misha Beltran

GU Research Digest for the week of September 6 - 12: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

5 things you should know about aggressive prostate cancer — from faster growth to treatment advances. Learn what sets it apart and why awareness matters: bit.ly/4nsvEoa #ProstateCancerAwarenessMonth Dana-Farber Lank Center for Genitourinary Oncology Dana-Farber